Rxcurve
HCPCS J1380 · per 10 MG

Estradiol valerate 10 mg inj

Products billed under this code include Delestrogen, Estradiol Valerate.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1380

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Delestrogen Endo USA, Inc. 42023-0110-01 5 $38.465
Delestrogen Endo USA, Inc. 42023-0111-01 10 $76.93
Estradiol Valerate Hikma Pharmaceuticals USA Inc. 00143-9289-01 5 $38.465
Estradiol Valerate Hikma Pharmaceuticals USA Inc. 00143-9290-01 10 $76.93
Estradiol Valerate Hikma Pharmaceuticals USA Inc. 00143-9291-01 20 $153.86
Estradiol Valerate American Regent, Inc. 00517-0420-01 10 $76.93
Estradiol Valerate American Regent, Inc. 00517-0440-01 20 $153.86
Estradiol Valerate Padagis US LLC 00574-0870-05 10 $76.93
Estradiol Valerate Padagis US LLC 00574-0872-05 20 $153.86
Estradiol Valerate Xiromed, LLC 70700-0273-22 5 $38.465
Show all 12 products
ProductLabelerNDCUnits / pkgLimit / pkg
Estradiol Valerate Xiromed, LLC 70700-0274-22 10 $76.93
Estradiol Valerate Xiromed, LLC 70700-0275-22 20 $153.86

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $7.693 −$0.009 10 MG Estradiol valerate 10 mg inj v1, posted September 17, 2026
3Q26 $7.702 +$0.513 10 MG Estradiol valerate 10 mg inj v1, posted September 15, 2026
2Q26 $7.189 −$0.257 10 MG Estradiol valerate 10 mg inj v1, posted September 15, 2026
1Q26 $7.446 +$0.198 10 MG Estradiol valerate 10 mg inj v1, posted September 15, 2026
4Q25 $7.248 −$0.464 10 MG Estradiol valerate 10 mg inj v1, posted September 8, 2026
3Q25 $7.712 +$0.411 10 MG Estradiol valerate 10 mg inj v1, posted March 10, 2026
2Q25 $7.301 −$0.641 10 MG Estradiol valerate 10 mg inj v1, posted March 10, 2026
1Q25 $7.942 +$0.437 10 MG Estradiol valerate 10 mg inj v1, posted December 19, 2025
4Q24 $7.505 −$0.818 10 MG Estradiol valerate 10 mg inj v1, posted June 11, 2025
3Q24 $8.323 −$0.333 10 MG Estradiol valerate 10 mg inj v1, posted June 11, 2025
2Q24 $8.656 −$0.58 10 MG Estradiol valerate 10 mg inj v1, posted March 11, 2025
1Q24 $9.236 −$1.386 10 MG Estradiol valerate 10 mg inj v1, posted December 19, 2024
4Q23 $10.622 −$0.16 10 MG Estradiol valerate 10 mg inj v1, posted October 10, 2024
3Q23 $10.782 +$0.733 10 MG Estradiol valerate 10 mg inj v1, posted June 5, 2024
2Q23 $10.049 −$1.104 10 MG Estradiol valerate 10 mg inj v1, posted February 23, 2024
1Q23 $11.153 +$0.794 10 MG Estradiol valerate 10 mg inj v1, posted December 6, 2023
4Q22 $10.359 +$0.556 10 MG Estradiol valerate 10 mg inj v1, posted June 22, 2023
3Q22 $9.803 −$0.292 10 MG Estradiol valerate 10 mg inj v1, posted June 9, 2023
2Q22 $10.095 −$0.633 10 MG Estradiol valerate 10 mg inj v1, posted December 14, 2022
1Q22 $10.728 −$0.54 10 MG Estradiol valerate 10 mg inj v1, posted June 8, 2022
4Q21 $11.268 +$0.315 10 MG Estradiol valerate 10 mg inj v1, posted June 2, 2022
3Q21 $10.953 +$0.74 10 MG Estradiol valerate 10 mg inj v1, posted June 2, 2022
2Q21 $10.213 −$1.292 10 MG Estradiol valerate 10 mg inj v1, posted March 1, 2022
1Q21 $11.505 – 10 MG Estradiol valerate 10 mg inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files